NanoGroup S.A. (WSE:NNG)
Poland · Delayed Price · Currency is PLN 2.330
-0.040 (-1.69%)
May 21, 2026, 4:43 PM CET
NanoGroup Revenue
NanoGroup had revenue of 8.00K PLN in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 8.00K, up 7,900.00% year-over-year.
Revenue (ttm)
8.00K
Revenue Growth
+7,900.00%
P/S Ratio
12,628.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
101.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 282.52M |
| Synthaverse | 42.01M |
| Mabion | 15.76M |
| Molecure | 6.52M |
| Captor Therapeutics Spolka Akcyjna | 4.66M |
| Urteste | 1.80M |
| Pharmena | 1.58M |
| Poltreg | 250.00K |